You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Investigational Drug Information for Ritanserin


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Ritanserin?

Ritanserin is an investigational drug.

There have been 3 clinical trials for Ritanserin. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 1992.

The most common disease conditions in clinical trials are Panic Disorder, Depressive Disorder, Major, and Depression. The leading clinical trial sponsors are Beth Israel Medical Center, National Institute on Drug Abuse (NIDA), and University of Pennsylvania.

Recent Clinical Trials for Ritanserin
TitleSponsorPhase
Risperidone vs. Paroxetine for Panic AttacksBeth Israel Medical CenterPhase 2
A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic AttacksBeth Israel Medical CenterN/A
Ritanserin in Treatment of Cocaine Dependence - 1National Institute on Drug Abuse (NIDA)Phase 2

See all Ritanserin clinical trials

Clinical Trial Summary for Ritanserin

Top disease conditions for Ritanserin
Top clinical trial sponsors for Ritanserin

See all Ritanserin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.